Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Franke

Showing results (141-150 of 280) with videos related to

Pageof 28
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|April 1, 1995
Comparative bioavailability of metronidazole formulations (Vagimid) after oral and vaginal administrationC Hoffmann, N Focke, G Franke, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Disposition kinetics of metronidazole in childrenI Amon, K Amon, H Scharp, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1993
Effects of nocloprost (9 beta-chloro-16,16-dimethyl PG E2) on absorption and disposition of antipyrine and sulfamethazine in healthy volunteersW Siegmund, M Zschiesche, G Franke, et al.
Journal of Interferon Research|October 1, 1989
Mouse interferon-gamma in liposomes: pharmacokinetics, organ-distribution, and activation of spleen and liver macrophages in vivoS Hockertz, G Franke, E Kniep, et al.
Journal of the Saudi Heart Association|August 21, 2013
Off-pump coronary revascularization: A potential benefit for female patients?Ahmed A Arifi, Erica Huen, J G Franke, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1988
N-acetylator phenotypes in hyperthyroidismW Siegmund, G Franke, S Meng, et al.
Frontiers in Public Health|November 17, 2022
Stimulant abuse as a coping strategy-Forensic and criminal consequences of stimulant abuse for neuroenhancementPhilipp Dominik, Martin P Waßmer, Michael Soyka, et al.
Nuclear Medicine and Biology|May 1, 1997
Uptake of 169Yb complexes in normal and tumour cells: influence of ligand and metabolic cell activity and stability of cellular associationG Kampf, G Knop, W G Franke, et al.
Radiologia Diagnostica|January 1, 1988
[Expanded evaluation possibilities of 123I-heptadecanoic acid metabolic studies of the myocardium using parametric scintigraphy]R Hliscs, W G Franke, J Ulrich, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 13, 2014
Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjectsAndreas G Franke, Christiana Bagusat, Sebastian Rust, et al.
Pageof 28

Showing results (141-150 of 280) with videos related to

Sort By:
Pageof 28
International Journal of Clinical Pharmacology and Therapeutics|April 1, 1995
Comparative bioavailability of metronidazole formulations (Vagimid) after oral and vaginal administrationC Hoffmann, N Focke, G Franke, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Disposition kinetics of metronidazole in childrenI Amon, K Amon, H Scharp, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1993
Effects of nocloprost (9 beta-chloro-16,16-dimethyl PG E2) on absorption and disposition of antipyrine and sulfamethazine in healthy volunteersW Siegmund, M Zschiesche, G Franke, et al.
Journal of Interferon Research|October 1, 1989
Mouse interferon-gamma in liposomes: pharmacokinetics, organ-distribution, and activation of spleen and liver macrophages in vivoS Hockertz, G Franke, E Kniep, et al.
Journal of the Saudi Heart Association|August 21, 2013
Off-pump coronary revascularization: A potential benefit for female patients?Ahmed A Arifi, Erica Huen, J G Franke, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1988
N-acetylator phenotypes in hyperthyroidismW Siegmund, G Franke, S Meng, et al.
Frontiers in Public Health|November 17, 2022
Stimulant abuse as a coping strategy-Forensic and criminal consequences of stimulant abuse for neuroenhancementPhilipp Dominik, Martin P Waßmer, Michael Soyka, et al.
Nuclear Medicine and Biology|May 1, 1997
Uptake of 169Yb complexes in normal and tumour cells: influence of ligand and metabolic cell activity and stability of cellular associationG Kampf, G Knop, W G Franke, et al.
Radiologia Diagnostica|January 1, 1988
[Expanded evaluation possibilities of 123I-heptadecanoic acid metabolic studies of the myocardium using parametric scintigraphy]R Hliscs, W G Franke, J Ulrich, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 13, 2014
Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjectsAndreas G Franke, Christiana Bagusat, Sebastian Rust, et al.
Pageof 28